vical inc (VICL:NASDAQ GS)
Robert H. Campbell
Former Director and Member of Nominating/Governance Committee, Vical Incorporated
|Age||Total Calculated Compensation||This person is connected to 9 board members in 1 different organizations across 4 different industries.|
See Board Relationships
Mr. Robert H. Campbell, also known as Bob serves as Managing Director of Lehman Brothers and Director of Public Finance, North Pacific Division, for more than five years. Mr. Campbell served as Chief Executive Officer of Sunoco Inc., a domestic refiner and marketer of petroleum products from September 1991 to June 2000 and its President from 1991 to 1996. Mr. Campbell's career began in research and development in 1960, and advanced through assignments in engineering, ...
10390 Pacific Center CourtPhone: 858-646-1100
San Diego, California 92121
Board Members Memberships*
Former Director, Chairman of Audit Committee, Member of Executive Committee, Member of Corporate Governance Committee, Member of Finance Committee and Member of People Resources Committee
Former Director, Chairman of Nominating & Corporate Governance Committee, Member of Compensation Committee, Member of Executive Committee and Member of Management Committee
Former Director and Member of Nominating/Governance Committee
Carnegie Mellon University
Massachusetts Institute of Technology
Annual Compensation*There is no Annual Compensation data available.
Stock Options*There is no Stock Options data available.
|J. Joseph Kim Ph.D.||Chief Executive Officer, President, Director and Member of Finance Committee|
Inovio Pharmaceuticals, Inc.
|Douglas J. Swirsky CPA, CFA||Chief Executive Officer, President, Corporate Secretary and Director|
|Jeffrey D. Abbey MBA, J.D.||Chief Executive Officer, President and Director|
Argos Therapeutics, Inc.
|Steven W. King||Chief Executive Officer, President, Director, Chief Executive Officer of Avid Bioservices Inc and President of Avid Bioservices Inc|
Peregrine Pharmaceuticals, Inc.
|Eddie Gray||Chief Executive Officer and Director|
Dynavax Technologies Corporation
|$533.3K||Compensation as of Fiscal Year 2013.|